GO:0019778 Atg12 activating enzyme activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019778 (Atg12 activating enzyme activity) is the molecular function that catalyzes ATP-dependent activation of the ubiquitin-like modifier Atg12 through formation of a high-energy thiolester bond.
• This activity is the first step of the Atg12 conjugation system, which ultimately produces the Atg12-Atg5 conjugate that acts as an E3-like enzyme for Atg8 lipidation.
• The Atg12-Atg5 conjugate enhances the E2 activity of Atg3 by rearranging its catalytic site, directly linking GO:0019778 to autophagosome membrane formation.
• Two ubiquitin-like conjugation systems, the Atg12 system and the Atg8 system, cooperate to mediate membrane formation during autophagy.
• Dysregulation of Atg12-dependent conjugation is implicated in motoneuron degeneration, inflammatory bowel disease, viral immune evasion, and cancer biology.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise interrogation of Atg12 activating enzyme activity in disease-relevant cell types.
Description
GO:0019778, Atg12 activating enzyme activity, is a molecular function that catalyzes the activation of the small ubiquitin-related modifier APG12 through the formation of an ATP-dependent high-energy thiolester bond. This activity represents the initiating enzymatic step of the Atg12 conjugation cascade, one of two ubiquitin-like conjugation systems that mediate membrane formation during autophagy. The reaction is essential because it primes Atg12 for covalent attachment to Atg5, generating the Atg12-Atg5 conjugate that functions as a novel E3-like enzyme for protein lipidation in autophagy. Researchers study GO:0019778 to understand how autophagosomes are formed, how cells respond to stress, and how defects in this conjugation system contribute to human disease. Because the Atg12-Atg5 conjugate enhances the E2 activity of Atg3 by rearranging its catalytic site, the activating enzyme activity encoded by GO:0019778 sits at a mechanistic hub connecting Atg12 conjugation to Atg8 lipidation and autophagosome expansion. Consequently, precise measurement and perturbation of Atg12 activating enzyme activity are central to autophagy research across neurodegeneration, inflammation, infection, and oncology.
Atg12 activating enzyme activity At A Glance
| GO ID | GO:0019778 |
|---|---|
| GO term | Atg12 activating enzyme activity |
| Ontology | molecular_function |
| Synonym | APG12 activating enzyme activity |
| Major function | ATP-dependent activation of Atg12 via high-energy thiolester bond formation, initiating Atg12 conjugation to Atg5 |
| Pathway context | Atg12 ubiquitin-like conjugation system, one of two systems mediating membrane formation during autophagy |
| Downstream product | Atg12-Atg5 conjugate with E3-like activity for Atg8 lipidation |
| Related activity | Enhancement of Atg3 E2 activity through catalytic site rearrangement |
| Disease relevance | Motoneuron degeneration, ulcerative colitis, SARS-CoV-2 immune evasion, cancer |
What Is GO:0019778?
Atg12 activating enzyme activity (GO:0019778) is defined as the catalysis of the activation of the small ubiquitin-related modifier APG12, through the formation of an ATP-dependent high-energy thiolester bond. In practical terms, this activity uses ATP to adenylate Atg12 and then transfers it to a catalytic cysteine residue of the activating enzyme, forming a thiolester-linked Atg12-enzyme intermediate. This intermediate is subsequently transferred to Atg5, producing the Atg12-Atg5 conjugate that acts as an E3-like factor for Atg8 lipidation. The term is a molecular_function in the Gene Ontology and is synonymous with APG12 activating enzyme activity.
Why Is Atg12 activating enzyme activity Important in Cell Biology?
Atg12 activating enzyme activity is important because it initiates the Atg12 conjugation cascade that produces the Atg12-Atg5 conjugate, a key E3-like factor for protein lipidation during autophagy. Without this ATP-dependent activation step, Atg12 cannot be conjugated to Atg5, and the downstream enhancement of Atg3 E2 activity that rearranges its catalytic site would not occur. Because autophagy is central to neuronal survival, intestinal homeostasis, antiviral defense, and tumor biology, the activity encoded by GO:0019778 is a mechanistically privileged node for understanding and manipulating these processes.
• Initiates the Atg12 ubiquitin-like conjugation system required for autophagosome membrane formation.
• Generates the Atg12-Atg5 conjugate that acts as an E3-like enzyme for Atg8 lipidation.
• Enhances Atg3 E2 activity by rearranging its catalytic site, linking Atg12 activation to Atg8 conjugation.
• Is implicated in motoneuron degeneration models where autophagy induction is protective.
• Is relevant to ulcerative colitis through PI3K/AKT/mTOR-regulated autophagy.
• Is targeted by the SARS-CoV-2 PLpro ubiquitin deconjugase, which regulates N-degron recognin-mediated autophagy.
• Represents a therapeutic opportunity via the ATG12-ATG3 protein-protein interaction.
• Provides a defined molecular function for CRISPR-based functional genomics of autophagy.
• Serves as a mechanistic anchor for interpreting autophagy-related gene expression and proteomics data.
• Connects ubiquitin-like conjugation biochemistry to human disease phenotypes.
What Happens During Atg12 activating enzyme activity?
ATP-dependent activation of Atg12
In simple terms: The enzyme uses ATP to switch Atg12 into a reactive form.
Atg12 activating enzyme activity catalyzes the activation of the small ubiquitin-related modifier APG12 through the formation of an ATP-dependent high-energy thiolester bond. This step consumes ATP and converts Atg12 into a form competent for transfer to downstream targets, representing the committed first step of the Atg12 conjugation system.
Thiolester intermediate formation
In simple terms: Atg12 becomes temporarily tethered to the enzyme through a high-energy bond.
The activation reaction proceeds through a high-energy thiolester bond between Atg12 and the activating enzyme. This thiolester intermediate is the defining chemical feature of GO:0019778 and provides the energy required for subsequent conjugation to Atg5.
Transfer to Atg5 and formation of the Atg12-Atg5 conjugate
In simple terms: Activated Atg12 is handed off to Atg5, forming a conjugate.
Following activation, Atg12 is conjugated to Atg5, yielding the Atg12-Atg5 conjugate. This conjugate has a novel E3-like activity for protein lipidation in autophagy, meaning it helps attach lipid molecules to Atg8-family proteins.
Enhancement of Atg3 E2 activity
In simple terms: The Atg12-Atg5 conjugate boosts the next enzyme in the chain.
The Atg12-Atg5 conjugate enhances the E2 activity of Atg3 by rearranging its catalytic site. This structural rearrangement links the activation step catalyzed by GO:0019778 to efficient Atg8 lipidation and autophagosome membrane formation.
Coordination with the Atg8 conjugation system
In simple terms: Two related conjugation systems work together to build the autophagosome.
Two ubiquitin-like conjugation systems, the Atg12 system and the Atg8 system, mediate membrane formation during autophagy. Atg12 activating enzyme activity is the entry point of the first system, and its output, the Atg12-Atg5 conjugate, functionally couples to the second system through Atg3.
Key Genes Involved in GO:0019778 Atg12 activating enzyme activity
The genes and proteins most directly associated with Atg12 activating enzyme activity include the ubiquitin-like modifier Atg12, its conjugation partner Atg5, the E2 enzyme Atg3, and the Atg8-family lipidation machinery, all of which have been characterized in autophagy conjugation studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATG12 | Ubiquitin-like modifier activated by GO:0019778 and conjugated to Atg5 | Core substrate for measuring activating enzyme activity and conjugation flux |
| ATG5 | Acceptor protein forming the Atg12-Atg5 conjugate with E3-like activity | Central readout of Atg12 conjugation and autophagosome formation |
| ATG3 | E2 enzyme whose activity is enhanced by the Atg12-Atg5 conjugate | Links Atg12 activation to Atg8 lipidation efficiency |
| ATG7 | Activating enzyme for ubiquitin-like conjugation systems in autophagy | Required for Atg12 activation and Atg8 conjugation |
| ATG10 | Activating enzyme for Atg12 conjugation | Directly catalyzes GO:0019778 and is a target for perturbation |
| ATG16L1 | Component of the Atg12-Atg5-Atg16 complex that specifies lipidation site | Scaffold linking Atg12 conjugation to membrane targeting |
| MAP1LC3B | Atg8-family protein lipidated downstream of Atg12-Atg5 | Readout of autophagosome formation and flux |
| GABARAP | Atg8-family protein subject to lipidation | Alternative Atg8-family readout for autophagy studies |
| TFEB | Transcription factor inducing autophagy genes including conjugation machinery | Upstream regulator of autophagy in neurodegeneration models |
| MTOR | Kinase regulating autophagy initiation | Pathway node controlling autophagy in inflammation models |
| PIK3CA | PI3K catalytic subunit in PI3K/AKT/mTOR signaling | Upstream signaling component in autophagy regulation |
| AKT1 | Kinase in PI3K/AKT/mTOR pathway | Modulates autophagy in disease models |
| PLPRO | SARS-CoV-2 ubiquitin deconjugase regulating N-degron recognin-mediated autophagy | Viral regulator of autophagy-related conjugation |
| ATG12-ATG3 interface | Protein-protein interaction target for autophagy modulation | Therapeutic target for autophagy modulation |
| SQSTM1 | Autophagy receptor relevant to N-degron recognin-mediated autophagy | Readout of selective autophagy |
| NBR1 | Autophagy receptor in N-degron recognin-mediated autophagy | Readout of selective autophagy |
| ULK1 | Upstream kinase in autophagy initiation | Regulatory node upstream of conjugation systems |
| BECN1 | Autophagy initiation factor | Context for interpreting conjugation system activity |
How Is Atg12 activating enzyme activity Regulated?
Atg12 activating enzyme activity operates within the broader autophagy regulatory network. In motoneuron degeneration models, trehalose induces autophagy via lysosomal-mediated TFEB activation, placing the conjugation machinery downstream of TFEB-dependent transcription. In ulcerative colitis models, oridonin ameliorates disease by regulating the PI3K/AKT/mTOR signaling pathway to activate autophagy, linking mTOR signaling to conjugation-dependent autophagosome formation. In viral infection, the SARS-CoV-2 PLpro ubiquitin deconjugase regulates N-degron recognin-mediated autophagy, showing that viral deconjugases can intersect with ubiquitin-like conjugation pathways. The Atg12-ATG3 protein-protein interaction has been proposed as a therapeutic target for autophagy modulation, indicating that the conjugation interface is itself a regulatory node.
Atg12 activating enzyme activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATG12 | Motoneuron degeneration and autophagy dysfunction | Knockout and overexpression in neuronal cell models |
| ATG5 | Autophagy-dependent inflammation and colitis | Point-mutation and knockout in intestinal epithelial cells |
| ATG3 | Cancer and autophagy modulation via ATG12-ATG3 interaction | Knock-in and point-mutation at the interaction interface |
| PLPRO | SARS-CoV-2 immune evasion and N-degron recognin-mediated autophagy | Overexpression and knockout in infected cell models |
| TFEB | Neurodegeneration with impaired autophagy induction | Overexpression and knockout in motoneuron models |
Neurodegeneration and motoneuron degeneration
Autophagy induction is protective in models of motoneuron degeneration, where trehalose induces autophagy via lysosomal-mediated TFEB activation. Because Atg12 activating enzyme activity initiates the conjugation cascade that builds autophagosomes, its functional status is mechanistically relevant to neuronal survival under proteotoxic stress.
Inflammatory bowel disease and ulcerative colitis
Oridonin ameliorates ulcerative colitis by regulating the PI3K/AKT/mTOR signaling pathway to activate autophagy. This places Atg12-dependent conjugation within the effector arm of autophagy activation in intestinal inflammation, where autophagosome formation is required for epithelial homeostasis.
Viral infection and immune evasion
The SARS-CoV-2 PLpro ubiquitin deconjugase regulates N-degron recognin-mediated autophagy. Because ubiquitin-like conjugation systems share chemistry with Atg12 activation, viral deconjugases can intersect with these pathways, making GO:0019778 relevant to host-pathogen interactions.
Cancer and therapeutic autophagy modulation
Targeting the ATG12-ATG3 protein-protein interaction has been proposed as a therapeutic opportunity in autophagy modulation. Since Atg12 activation is upstream of the Atg12-Atg5 conjugate that enhances Atg3 activity, the ATG12-ATG3 interface represents a druggable node connected to GO:0019778.
From Atg12 activating enzyme activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is Atg12 activating enzyme activity required for autophagosome formation? | ATG10 or ATG7 knockout cell lines with LC3B lipidation readouts |
| Does a point mutation in the catalytic cysteine abolish thiolester formation? | Point-mutation knock-in of the catalytic residue in ATG10 |
| How does the Atg12-Atg5 conjugate enhance Atg3 activity? | Knock-in of tagged ATG12 and ATG5 for structural and biochemical assays |
| Does overexpression of conjugation machinery increase autophagic flux? | Overexpression of ATG12, ATG5, and ATG3 in disease-relevant cells |
| Can the ATG12-ATG3 interaction be therapeutically modulated? | Knock-in and point-mutation models targeting the ATG12-ATG3 interface |
| How does viral PLpro affect N-degron recognin-mediated autophagy? | Overexpression and knockout of PLPRO in infected cell models |
How to Study the Atg12 activating enzyme activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Thiolester assay | ATP-dependent high-energy thiolester bond formation | Direct measurement of GO:0019778 activity |
| Immunoblot for Atg12-Atg5 conjugate | Level of Atg12-Atg5 conjugate | Readout of Atg12 conjugation flux |
| LC3B lipidation assay | Lipidated Atg8-family protein | Functional readout of downstream lipidation |
| Co-immunoprecipitation | Atg12-ATG3 and related interactions | Mapping conjugation protein complexes |
| Proteomics | Conjugation machinery abundance and modifications | Systems-level analysis of autophagy conjugation |
| Transcriptomics | Expression of autophagy and conjugation genes | Pathway analysis in disease models |
| Fluorescence imaging | Autophagosome formation and localization | Visualizing membrane formation during autophagy |
| CRISPR functional genomics | Gene requirement for conjugation and autophagy | Perturbation of Atg12 pathway components |
Biochemical thiolester assays
Because GO:0019778 is defined by ATP-dependent high-energy thiolester bond formation, biochemical assays that detect the Atg12-enzyme thiolester intermediate are the most direct way to measure this activity. These assays typically use recombinant activating enzyme and Atg12 under ATP-containing conditions and resolve thiolester-linked species.
Conjugation and lipidation readouts
The downstream products of Atg12 activation, namely the Atg12-Atg5 conjugate and lipidated Atg8-family proteins, can be monitored to infer pathway activity. The Atg12-Atg5 conjugate has E3-like activity for protein lipidation, so lipidation status of LC3B or GABARAP serves as a functional readout.
Proteomics and interaction mapping
The Atg12-ATG3 protein-protein interaction has been structurally characterized, and interaction mapping can reveal how conjugation components assemble. Proteomic approaches can quantify Atg12-Atg5 conjugate levels and associated factors in disease models.
Transcriptomic and pathway analysis
Autophagy induction through TFEB and the PI3K/AKT/mTOR pathway can be assessed by transcriptomic and pathway analysis in disease models. Such analyses place Atg12 activating enzyme activity within upstream regulatory networks that control conjugation gene expression.
How CRISPR Can Be Used to Study GO:0019778 Atg12 activating enzyme activity
Knockout
CRISPR knockout of ATG10, ATG7, ATG12, or ATG5 can abolish Atg12 activating enzyme activity and downstream conjugation, providing a clean loss-of-function background to test whether a phenotype depends on this molecular function. Knockout models are also useful for validating autophagy-dependent effects in disease contexts such as colitis and neurodegeneration.
Point Mutation
Point mutation of the catalytic cysteine residue in the activating enzyme can specifically disable thiolester formation while preserving protein expression, allowing separation of catalytic activity from scaffolding functions. Such point-mutation models are valuable for testing whether GO:0019778 catalytic activity, rather than protein abundance, drives a phenotype.
Knock-in
Knock-in of tagged ATG12 or ATG5 enables affinity purification and structural analysis of the conjugation machinery, including the Atg12-Atg5 conjugate that enhances Atg3 E2 activity. Tagged knock-in models also permit tracking of conjugate localization during autophagosome formation.
Overexpression
Overexpression of ATG12, ATG5, and ATG3 can amplify conjugation flux and lipidation readouts, which is useful for studying the ATG12-ATG3 interaction and its therapeutic modulation. Overexpression models also help test whether increasing Atg12 activating enzyme activity is sufficient to enhance autophagy in disease-relevant cells.
How EDITGENE Supports Atg12 activating enzyme activity Research
Researchers studying Atg12 activating enzyme activity-related genes often need to determine whether a candidate gene is causally involved in conjugation, autophagosome formation, or disease phenotypes, rather than merely correlated with them. Establishing causality requires precise genetic perturbation, ideally combining loss-of-function, catalytic-dead point mutations, tagged knock-ins, and controlled overexpression in the same cellular background. EDITGENE provides these CRISPR-based models and the bioinformatics support needed to interpret conjugation and autophagy readouts in disease contexts.
Contact EDITGENE today to design your custom CRISPR model for Atg12 activating enzyme activity research.
Frequently Asked Questions About Atg12 activating enzyme activity
What is Atg12 activating enzyme activity?
Atg12 activating enzyme activity (GO:0019778) is the catalysis of the activation of the small ubiquitin-related modifier APG12 through the formation of an ATP-dependent high-energy thiolester bond.
What is the GO ID for Atg12 activating enzyme activity?
The Gene Ontology ID for Atg12 activating enzyme activity is GO:0019778, and it belongs to the molecular_function ontology.
What genes are involved in Atg12 activating enzyme activity?
Key genes include ATG12 as the ubiquitin-like modifier, ATG10 and ATG7 as activating enzymes, ATG5 as the conjugation partner, and ATG3 as the E2 enzyme enhanced by the Atg12-Atg5 conjugate.
What does Atg12 activating enzyme activity do in autophagy?
It initiates the Atg12 conjugation system, producing the Atg12-Atg5 conjugate that acts as an E3-like enzyme for protein lipidation during autophagosome membrane formation.
How is Atg12 activating enzyme activity measured?
It can be measured by biochemical thiolester assays detecting the ATP-dependent high-energy thiolester bond, and functionally inferred from Atg12-Atg5 conjugate levels and Atg8-family lipidation.
Why is Atg12 activating enzyme activity important in disease?
It is mechanistically linked to motoneuron degeneration, ulcerative colitis, SARS-CoV-2 immune evasion, and cancer, where autophagy modulation affects disease outcomes.
How does the Atg12-Atg5 conjugate relate to Atg12 activating enzyme activity?
The Atg12-Atg5 conjugate is the product of Atg12 activation and conjugation, and it has a novel E3-like activity for protein lipidation in autophagy.
Does the Atg12-Atg5 conjugate affect Atg3?
Yes, the Atg12-Atg5 conjugate enhances the E2 activity of Atg3 by rearranging its catalytic site.
What are the two ubiquitin-like conjugation systems in autophagy?
The Atg12 system and the Atg8 system are the two ubiquitin-like conjugation systems that mediate membrane formation during autophagy.
How can CRISPR help study Atg12 activating enzyme activity?
CRISPR knockout, point mutation, knock-in, and overexpression models can abolish, disable, tag, or amplify Atg12 activating enzyme activity to test causality in autophagy and disease.
Conclusion
Atg12 activating enzyme activity (GO:0019778) is the ATP-dependent, thiolester-forming step that initiates the Atg12 conjugation system and ultimately generates the Atg12-Atg5 conjugate with E3-like activity for protein lipidation. Its output enhances Atg3 E2 activity and couples to the Atg8 conjugation system during autophagosome membrane formation. Because this activity is implicated in neurodegeneration, inflammatory bowel disease, viral infection, and cancer, it is a high-value target for CRISPR-based functional studies. EDITGENE supports these studies with knockout, point-mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to Atg12 pathway research.
References
- 1. Rusmini P et al.. 2019. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.. Autophagy 15(4):631-651 PMID: 30335591
- 2. Miao Z et al.. 2026. Oridonin ameliorates ulcerative colitis by regulating the PI3K/AKT/mTOR signaling pathway to activate autophagy.. Int J Mol Med 58(2) PMID: 42318949
- 3. Ayala-Torres C et al.. 2025. Regulation of N-degron recognin-mediated autophagy by the SARS-CoV-2 PLpro ubiquitin deconjugase.. Autophagy 21(5):1019-1038 PMID: 39723606
- 5. Hanada T et al.. 2007. The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy.. J Biol Chem 282(52):37298-302 PMID: 17986448
- 6. Kamel EM et al.. 2025. Targeting the ATG12-ATG3 protein-protein interaction: From structural insights to therapeutic opportunities in autophagy modulation.. Pathol Res Pract 273:156156 PMID: 40763565
- 7. Sakoh-Nakatogawa M et al.. 2013. Atg12-Atg5 conjugate enhances E2 activity of Atg3 by rearranging its catalytic site.. Nat Struct Mol Biol 20(4):433-9 PMID: 23503366
- 8. Nakatogawa H. 2013. Two ubiquitin-like conjugation systems that mediate membrane formation during autophagy.. Essays Biochem 55:39-50 PMID: 24070470
